课题基金 / 基金详情

Breaking selective constraints: is Hsp90 a capacitor of evolutionary change?

Breaking selective constraints: is Hsp90 a capacitor of evolutionary change?
打破选择性限制:Hsp90 是进化变化的电容器吗?
批准号:
DP0557494
负责人:
Prof Carla Sgro
金额:
$47.57万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-10-31 至 2010-12-31

项目摘要

项目成果

Prof Carla Sgro的其他基金

相似基金

相关文献

中文摘要
翻译
基因的作用和表达可以通过遗传机制进行调节。如果存在一种易于操纵的控制基因表达的一般机制,就有可能使动植物育种者能够快速产生和选择具有农业重要性的新性状,而不需要依赖转基因和长期育种计划。它还将帮助开发工具,以识别和检测增加人类疾病易感性的基因,如癌症,这些疾病只有在某些环境条件下才能表达。我打算确定Hsp90蛋白是否代表了一种控制基因表达的一般机制。
英文摘要
Gene action and expression can be modulated by genetic mechanisms. If a general mechanism controlling gene expression exists that can be easily manipulated it has the potential to allow animal and plant breeders to quickly produce and select for new characters of agricultural importance without relying on transgenics and long-term breeding programs. It would also assist in the development of tools for identifying and detecting genes that increase susceptibility to human diseases, such as cancer, that are only expressed under certain conditions environmental. I intend to determine whether the protein Hsp90 represents a general mechanism controlling gene expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fitness and evolutionary consequences of developmental plasticity
  • 批准号:
    DP240102830
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $31.13万
  • 财政年份:
    2024
  • 负责人:
    Prof Carla Sgro
  • 依托单位:
Genomic vulnerability
  • 批准号:
    DP220102958
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $40.7万
  • 财政年份:
    2022
  • 负责人:
    Prof Carla Sgro
  • 依托单位:
Are the sexes really equal? Sex-specific adaptation to environmental change
  • 批准号:
    DP200102754
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.68万
  • 财政年份:
    2020
  • 负责人:
    Prof Carla Sgro
  • 依托单位:
Multiple stressors and vulnerability to global change
  • 批准号:
    DP180103725
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $20.63万
  • 财政年份:
    2018
  • 负责人:
    Prof Carla Sgro
  • 依托单位:
国内基金
海外基金
新型M4受体选择性拮抗剂的研究